<--- Back to Details
First PageDocument Content
Bristol-Myers Squibb / Cetuximab / Pancreatic cancer / Radiation therapy / Epidermal growth factor receptor / Cancer / Targeted therapy / Radioimmunotherapy / Hepatocellular carcinoma / Medicine / Radiation oncology / Medical physics
Date: 2011-01-12 10:46:25
Bristol-Myers Squibb
Cetuximab
Pancreatic cancer
Radiation therapy
Epidermal growth factor receptor
Cancer
Targeted therapy
Radioimmunotherapy
Hepatocellular carcinoma
Medicine
Radiation oncology
Medical physics

Clinical Cancer Research

Add to Reading List

Source URL: www.kanziuscancerresearch.org

Download Document from Source Website

File Size: 2,12 MB

Share Document on Facebook

Similar Documents

IJC International Journal of Cancer Acetyl-11-keto-b-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

DocID: 1v41o - View Document

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Endometrial cancer (LUK) Kidney cancer (LUK) Pancreatic cancer Stomach cancer I)

DocID: 1uwW9 - View Document

Exercise – Viewing gene features on the mouse karyotype Several variants seem to be associated with pancreatic cancer. Here is a non-exhaustive list of genes where these variants have been mapped to in humans: ABO, TP

DocID: 1uuDx - View Document

David Mundy The role of the SWI/SNF complexes in pancreatic cancer Pancreatic ductal adenocarcinoma, known colloquially as pancreatic cancer (PC), is the eighth leading cause of cancer-related mortality worldwide1. Due t

DocID: 1tQq2 - View Document